Mycronic Lifts 2026 Sales Target After Record First-Quarter Earnings

Mycronic AB ( (SE:MYCR) ) has provided an update.

Mycronic opened 2026 with record quarterly performance, as order intake rose 23 percent to SEK 2,529 million and net sales climbed 17 percent to SEK 2,503 million, or 32 percent at constant exchange rates. EBIT reached an all-time high of SEK 938 million with a 37 percent margin, supported by the first delivery of the Prexision 8000 Evo and growth across all four divisions, despite ongoing weakness in European and U.S. PCB assembly demand.

Strong momentum in Global Technologies, High Volume systems and AI-related PCB test and optical communications drove healthy demand and a stable photomask market, while integration of the Cowin DST acquisition and the purchase of German test probe maker ETZ broadened the group’s technology base. On the back of a solid order backlog and early 2026 order strength, the board raised its full-year net sales target from SEK 8.25 billion to SEK 8.75 billion, signaling increased confidence in sustained growth and earnings power.

More about Mycronic AB

Mycronic AB is a Swedish high-tech company that supplies advanced production equipment to the electronics industry. Its portfolio spans pattern generators for display and semiconductor photomasks, PCB assembly solutions, high-volume production systems and PCB test and die bonding technologies, serving markets from consumer electronics and optical communications to AI-driven data centers and aerospace.

Average Trading Volume: 288,096

Technical Sentiment Signal: Buy

Current Market Cap: SEK53.07B

See more data about MYCR stock on TipRanks’ Stock Analysis page.